Istockphoto
Scientists have successfully used a leukemia drug to reverse type 1 diabetes—at least in mice. Researchers at the University of California, San Francisco and Plexxikon, a pharmaceutical research firm, studied two cancer drugs—Gleevec (imatinib) and Sutent (sunitinib)—in non-obese diabetic mice, which were prone to developing diabetes.
Both drugs are tyrosine kinase inhibitors, which interfere with cell communication and growth and are used to fight tumors. Gleevec is prescribed for chronic myelogenous leukemia and Sutent is used to treat advanced kidney cancer and a type of stomach cancer. Read More
In my household, budgeting for next year’s medical expenditures—supplies for diabetes, drugs for asthma, and medications for allergies—begins in October. This is the time when both my wife and I receive our benefit packages from work.
Even if you take insulin every day (as I do), plunging a needle into your skin never gets comfortable—which is why I try to avoid additional, unnecessary pokes.
When food prices began rising this summer, my family’s weekly grocery bills jumped from $150 to $200. (This amount does not include what we were spending eating out, but does include expenses for diapers, paper goods, and other sundries.)
If someone gave awards to diabetics for smart lunchroom choices, I’d win every one in my company’s meager cafeteria: Two or three servings of veggies and a 2- to 4-ounce serving of meat, skip the bread. Just what this diabetic needs to manage his blood sugar.
Researchers looking for the cause of 
